Analyst Consensus ?
ConsensusBuy32 ratings
Bullish2578.1%
Neutral721.9%
Bearish00.0%
FN2 Earnings Intelligence
Marathon Petroleum Corporation (MPC) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 21, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Raymond James | Outperform | Outperform | Maintain | Sep 14, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Sep 14, 2026 |
| UBS | Buy | Buy | Maintain | Sep 8, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Sep 3, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Sep 1, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Aug 11, 2026 |
| Barclays | Overweight | Overweight | Maintain | Aug 6, 2026 |
| TD Cowen | Buy | Buy | Maintain | Aug 5, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Aug 5, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Aug 5, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Jul 22, 2026 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Apr 22, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Feb 9, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Sep 3, 2025 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Jul 14, 2025 |
| JP Morgan | Neutral | Neutral | Maintain | Oct 9, 2024 |
| Jefferies | Buy | Buy | Maintain | Jul 15, 2024 |
| RBC Capital | Outperform | Outperform | Maintain | Aug 2, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Feb 1, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | May 4, 2022 |
| Macquarie | Outperform | Outperform | Maintain | Feb 6, 2019 |
| Standpoint Research | Buy | Accumulate | Maintain | Dec 26, 2018 |
| Bank of America | Buy | Neutral | Upgrade | May 10, 2018 |
| Deutsche Bank | Buy | Buy | Maintain | Mar 19, 2018 |
| PiperJaffray | Neutral | Neutral | Maintain | Sep 16, 2016 |
| Scotia Howard Weil | Sector Outperform | Sector Perform | Upgrade | Dec 15, 2015 |
| Oppenheimer | Outperform | Perform | Upgrade | May 27, 2015 |
| S&P Capital IQ | Buy | Hold | Upgrade | Jul 3, 2014 |
| Imperial Capital | Outperform | In Line | Upgrade | Jan 31, 2014 |
| ISI Group | Buy | Neutral | Upgrade | Jan 30, 2014 |
| Simmons & Co. | Overweight | Neutral | Upgrade | Dec 2, 2013 |
| Tudor Pickering | Buy | Buy | Maintain | Jul 23, 2012 |
Upside is calculated against the persisted current price $413.62. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Raymond James | Analyst unavailable | $445 | $404.77 | +7.6% | Sep 14, 2026 |
| Morgan Stanley | Joe Laetsch | $453 | $407.14 | +9.5% | Sep 14, 2026 |
| UBS | Analyst unavailable | $450 | $388.9 | +8.8% | Sep 8, 2026 |
| Piper Sandler | John Royall | $462 | $387 | +11.7% | Sep 3, 2026 |
| Wells Fargo | Analyst unavailable | $400 | $373.32 | -3.3% | Sep 1, 2026 |
| Mizuho Securities | Analyst unavailable | $304 | $320.32 | -26.5% | Aug 11, 2026 |
| Piper Sandler | John Royall | $344 | $300.09 | -16.8% | Aug 6, 2026 |
| Barclays | Analyst unavailable | $321 | $297.75 | -22.4% | Aug 6, 2026 |
| Evercore ISI | Analyst unavailable | $330 | $310.71 | -20.2% | Aug 5, 2026 |
| Wells Fargo | Analyst unavailable | $359 | $312.61 | -13.2% | Aug 5, 2026 |
| Piper Sandler | Analyst unavailable | $343 | $315.82 | -17.1% | Jul 23, 2026 |
| Raymond James | Justin Jenkins | $335 | $294.06 | -19.0% | Jul 13, 2026 |
| Barclays | Analyst unavailable | $289 | $283.74 | -30.1% | Jul 13, 2026 |
| Jefferies | Analyst unavailable | $335 | $283.74 | -19.0% | Jul 12, 2026 |
| UBS | Manav Gupta | $321 | $280.61 | -22.4% | Jul 10, 2026 |
| Wells Fargo | Sam Margolin | $344 | $263.58 | -16.8% | Jun 15, 2026 |
| Morgan Stanley | Analyst unavailable | $265 | $260.81 | -35.9% | Jun 12, 2026 |
| Mizuho Securities | Analyst unavailable | $284 | $248.05 | -31.3% | May 27, 2026 |
| UBS | Analyst unavailable | $285 | $249.32 | -31.1% | May 6, 2026 |
| Barclays | Analyst unavailable | $270 | $260.51 | -34.7% | May 6, 2026 |
| Morgan Stanley | Joe Laetsch | $233 | $221.1 | -43.7% | Apr 24, 2026 |
| Barclays | Analyst unavailable | $230 | $220.27 | -44.4% | Apr 10, 2026 |
| Piper Sandler | Analyst unavailable | $228 | $223.52 | -44.9% | Apr 9, 2026 |
| BMO Capital | Phillip Jungwirth | $225 | $203.91 | -45.6% | Feb 9, 2026 |
| UBS | Manav Gupta | $221 | $203.63 | -46.6% | Feb 6, 2026 |
| Wells Fargo | Analyst unavailable | $217 | $187.58 | -47.5% | Feb 4, 2026 |
| Scotiabank | Paul Cheng | $174 | $176.1 | -57.9% | Jan 16, 2026 |
| Mizuho Securities | Analyst unavailable | $205 | $175.54 | -50.4% | Jan 13, 2026 |
| Piper Sandler | Analyst unavailable | $184 | $172.51 | -55.5% | Jan 8, 2026 |
| Mizuho Securities | Analyst unavailable | $196 | $186.97 | -52.6% | Dec 12, 2025 |
| Raymond James | Justin Jenkins | $200 | $184.54 | -51.6% | Nov 4, 2025 |
| Raymond James | Justin Jenkins | $203 | $181.15 | -50.9% | Oct 17, 2025 |
| Barclays | Theresa Chen | $194 | $180.89 | -53.1% | Oct 13, 2025 |
| Scotiabank | Analyst unavailable | $189 | $189.06 | -54.3% | Oct 9, 2025 |
| Morgan Stanley | Analyst unavailable | $200 | $192.24 | -51.6% | Oct 3, 2025 |
| UBS | Analyst unavailable | $220 | $196.44 | -46.8% | Sep 26, 2025 |
| Evercore ISI | Stephen Richardson | $170 | $167.42 | -58.9% | Jun 18, 2025 |
| Raymond James | Analyst unavailable | $193 | $147.35 | -53.3% | Mar 27, 2025 |
| Barclays | Analyst unavailable | $161 | $141.15 | -61.1% | Mar 14, 2025 |
| Morgan Stanley | Joe Laetsch | $174 | $151.06 | -57.9% | Dec 19, 2024 |
| Bank of America Securities | Jean Ann Salisbury | $174 | $157.9 | -57.9% | Oct 17, 2024 |
| Scotiabank | Paul Cheng | $170 | $162.61 | -58.9% | Oct 10, 2024 |
| Piper Sandler | Ryan Todd | $145 | $164.22 | -64.9% | Sep 24, 2024 |
| UBS | Manav Gupta | $189 | $163.58 | -54.3% | Sep 14, 2024 |
| Wolfe Research | Doug Leggate | $200 | $165.56 | -51.6% | Jul 17, 2024 |
| Jefferies | Lloyd Byrne | $231 | $165.46 | -44.2% | Jul 14, 2024 |
| Wells Fargo | Roger Read | $196 | $164.29 | -52.6% | Jul 12, 2024 |
| Mizuho Securities | Nitin Kumar | $201 | $172.45 | -51.4% | Jun 20, 2024 |
| Piper Sandler | Ryan Todd | $168 | $168.9 | -59.4% | Jun 14, 2024 |
| Raymond James | Justin Jenkins | $230 | $174.66 | -44.4% | May 30, 2024 |
| Piper Sandler | Ryan Todd | $190 | $177.86 | -54.1% | May 14, 2024 |
| Mizuho Securities | Nitin Kumar | $203 | $179.56 | -50.9% | May 13, 2024 |
| Barclays | Theresa Chen | $195 | $182.55 | -52.9% | May 6, 2024 |
| Mizuho Securities | Nitin Kumar | $202 | $212.27 | -51.2% | Apr 12, 2024 |
| Piper Sandler | Ryan Todd | $204 | $216.25 | -50.7% | Apr 5, 2024 |
| Wells Fargo | Roger Read | $227 | $214.96 | -45.1% | Apr 4, 2024 |
| Mizuho Securities | Nitin Kumar | $160 | $128.38 | -61.3% | Mar 10, 2023 |
| UBS | Manav Gupta | $165 | $129.41 | -60.1% | Mar 9, 2023 |
| Cowen & Co. | Analyst unavailable | $143 | $123.85 | -65.4% | Feb 1, 2023 |
| Wells Fargo | Analyst unavailable | $153 | $125.67 | -63.0% | Feb 1, 2023 |
| Raymond James | Analyst unavailable | $165 | $128.52 | -60.1% | Feb 1, 2023 |
| Raymond James | Analyst unavailable | $155 | $122.08 | -62.5% | Jan 13, 2023 |
| Piper Sandler | Analyst unavailable | $143 | $109.75 | -65.4% | Dec 19, 2022 |
| Wells Fargo | Roger Read | $117 | $95.79 | -71.7% | Aug 16, 2022 |
| BMO Capital | Phillip Jungwirth | $135 | $84.48 | -67.4% | Jun 29, 2022 |
| Wells Fargo | Roger Read | $129 | $102.17 | -68.8% | Jun 14, 2022 |
| Credit Suisse | Analyst unavailable | $110 | $93.42 | -73.4% | May 4, 2022 |
| Citigroup | Analyst unavailable | $108 | $84.86 | -73.9% | Apr 26, 2022 |
| Morgan Stanley | Connor Lynagh | $115 | $84.08 | -72.2% | Apr 25, 2022 |
| Wells Fargo | Analyst unavailable | $110 | $90.98 | -73.4% | Apr 21, 2022 |
| Citigroup | Prashant Rao | $85 | $72.81 | -79.4% | Jan 19, 2022 |
| Barclays | Theresa Chen | $80 | $72.16 | -80.7% | Jan 11, 2022 |
| Bank of America Securities | Doug Leggate | $88 | $69.93 | -78.7% | Jan 10, 2022 |
| UBS | Lloyd Byrne | $73 | $63.11 | -82.4% | Nov 17, 2021 |
| Goldman Sachs | Neil Mehta | $73 | $62.66 | -82.4% | Nov 3, 2021 |
| Wolfe Research | Sam Margolin | $68 | $55.29 | -83.6% | May 4, 2021 |
Track every rating change on MPC the moment it posts. Free to start.
Start freeOne email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.